Cargando…

ODP502 Nodular Pretibial Myxedema without Graves’ Orbitopathy: A Case Report

BACKGROUND: Nodular myxedema is an uncommon skin manifestation of autoimmune thyroid disease. Almost always associated with significant orbitopathy from the deposition of glycosaminoglycans by stimulated fibroblasts. CLINICAL CASE: A 57-year-old male presented to dermatology clinic with multiple, no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veeramachaneni, Ravali, White-Cotsmire, Alexander, Norwick, Paige, Demidova, Olga, Roseberg, Arlene, del Rincon, Juan P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Thyroid
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625664/ http://dx.doi.org/10.1210/jendso/bvac150.1602

Ejemplares similares

ODP516 Subacute Thyroiditis due to SARS-CoV-2 Vaccine
por: Veeramachaneni, Ravali, et al.
Publicado: (2022)

ODP524 Thyroid Storm Precipitated by COVID-19 Infection: A Case Report
por: Veeramachaneni, Ravali, et al.
Publicado: (2022)

ODP531 Worsening of pretibial myxedema following repeated doses of radioiodine treatment in a patient with hyperthyroid Graves’ disease
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2022)

PSAT358 Graves’ Disease Complicated by Post-Operative Graves’ Ophthalmopathy and Pretibial Myxedema
por: Bowens, Brendan, et al.
Publicado: (2022)

SAT-471 A Rare Case of Pretibial Myxedema Preceding Graves’ Hyperthyroidism
por: Bao, Ginny W, et al.
Publicado: (2020)

ODP530 When "Taller-Than-Wide" Is Not Taller-Than-Wide
por: Khan, Anum, et al.
Publicado: (2022)

SUN-576 Abrupt Switching From Hypertyroidism To Hypothyroidism With Pretibial Myxedema And Acropachy, In Graves’ Ophthalmopathy: Case Report.
por: Ferreira, Eduardo, et al.
Publicado: (2019)

ODP482 Graves Orbitopathy Secondary to Alemtuzumab Infusion for Multiple Sclerosis
por: Alam, Mustafa, et al.
Publicado: (2022)

MON-601 Optimizing the Mean TSH Target Range for Thyroid Hormone (L-T4) Replacement in Primary Hypothyroidism
por: Siddiqui, Mahwash, et al.
Publicado: (2019)

FRI554 Pretibial Myxedema Associated With Hashimoto Thyroiditis Treated With Teprotumumab
por: Marta Niedzialkowska, Ewelina, et al.
Publicado: (2023)

MON-572 Assessing Error in the Referencing of Thyroid Nodule Size by Longest Dimension (LD) and by Volume (Vol)
por: Al Anbari, Raghda, et al.
Publicado: (2019)

ODP491 Levothyroxine Withdrawal Presenting as Myxedema Madness
por: Trusty, Rhonda-Kaye, et al.
Publicado: (2022)

MON-626 Survey of Thyroid Antibody Positivity and Treated Hashimoto’s Disease in Nodular Thyroid Disorders
por: Unjom, Zubina, et al.
Publicado: (2019)

ODP210 Impact of Continuous Glucose Monitoring (CGM) in the Intensive Care Units (ICUs): Accuracy, Reliability, Feasibility and Nurse Acceptance
por: del Rincon, Juan, et al.
Publicado: (2022)

MON-529 The Impact of The Association of Unnecessarily Ordered Thyroid Ultrasounds (USGS) and Unnecessarily Requested Endocrinology Consultations
por: Veeramachaneni, Ravali, et al.
Publicado: (2020)

ODP499 Myxedema Coma: A Challenging Presentation of an Uncommon Disease
por: Figueroa, Alegyari, et al.
Publicado: (2022)

Resolution of pretibial myxedema with teprotumumab in a patient with Graves disease
por: Varma, Aakaash, et al.
Publicado: (2020)

Worsening of pretibial myxedema following radioiodine treatment for hyperthyroid Graves’ disease
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2023)

SAT-554 Teprotumumab in Graves' Orbitopathy: Extended Outcome Analyses
por: Kahaly, George, et al.
Publicado: (2019)

SAT-429 Systemic Safety Analysis of Mycophenolate in Graves’ Orbitopathy
por: Lee, Alan C H, et al.
Publicado: (2020)

Teprotumumab for Treatment of Pretibial Myxedema
por: Reyes, Michelangelo P, et al.
Publicado: (2023)

ODP533 Graves’ Ophthalmopathy in the Setting of Primary Hypothyroidism
por: Alajmi, Sarah, et al.
Publicado: (2022)

A case of Tocilizumab-induced thrombocytopenia in steroid-resistant Graves orbitopathy
por: Cuculescu, Victoria, et al.
Publicado: (2023)

ODP570 Immunotherapy and its Implications for the Future of Endocrinology: A Case Discussion of Pembrolizumab Induced Myxedema Coma
por: Coppinger, Anna, et al.
Publicado: (2022)

FRI502 Myxedema Coma With An Unusual Pattern Of Thyroid Function Tests Due To Amiodarone-induced Hypothyroidism
por: Nguyen, Son, et al.
Publicado: (2023)

ODP506 Posterior Staphyloma misdiagnosed as unilateral Grave's ophthalmopathy
por: Houri, Muhammad
Publicado: (2022)

ODP452 A Case of Thymic Hyperplasia in Graves’ Disease
por: Ahmed, Ammar, et al.
Publicado: (2022)

ODP517 Successful Treatment of Myxedema Coma after SARS-CoV-2 infection with Combination Oral Levothyroxine and Liothyronine
por: Dimayuga, Diana Colleen, et al.
Publicado: (2022)

SAT-606 Graves' Orbitopathy Treated with Kahaly's Protocol: IV High Dose Glucocorticoids
por: Patel, Bijal, et al.
Publicado: (2019)

ODP447 A Case of Hidden Grave's After Total Thyroidectomy
por: Baghel, Annavi, et al.
Publicado: (2022)

ODP574 Characteristics of Grave's Disease Among Children and Adolescents in KSA
por: Alradadi, Rasha, et al.
Publicado: (2022)

Pretibial Myxedema Presenting as Severe Elephantiasis
por: Lee, Jae-Hoon, et al.
Publicado: (2018)

SUN-502 Graves’Disease and Autoimmune Hepatitis: Management Challenges
por: Soares, Maria Marta Sarquis, et al.
Publicado: (2020)

SAT-421 Novel Role of Chloroquine and Hydroxychloroquine in Graves’ Orbitopathy Therapy by Targeting Orbital Fibroblasts
por: Guo, Yan, et al.
Publicado: (2020)

A Unique Presentation of Metastatic Follicular Thyroid Cancer Associated with Hyperthyroidism and an Active Graves’ Orbitopathy
por: Al-Jundi, Mohammad, et al.
Publicado: (2021)

ODP523 Thyroid Storm in a Patient With Alemtuzumab Induced Graves’ Disease
por: AlShehri, Sara, et al.
Publicado: (2022)

ODP614 Two cases of Graves Disease Associated Hypokalemic Periodic Paralysis
por: Reddy Bendaram, Snigdha, et al.
Publicado: (2022)

Rapidly Progressive Cognitive Decline and Varicella Zoster Blisters Associated With Teprotumumab in 2 Patients With Graves’ Orbitopathy
por: Hoang, Thanh Duc, et al.
Publicado: (2021)

ODP615 Emergence of Graves’ Ophthalmopathy in the Setting of Sudden Hypothyroidism: Possible Mechanisms Explored
por: Suelto, Jeremy Anne, et al.
Publicado: (2022)

Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab
por: Bowens, Brendan K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5ssmfvqqguq4h0mr83sm04rmim